198 related articles for article (PubMed ID: 18560420)
1. Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes.
Nakamura T; Moriguchi R; Kogure K; Shastri N; Harashima H
Mol Ther; 2008 Aug; 16(8):1507-14. PubMed ID: 18560420
[TBL] [Abstract][Full Text] [Related]
2. Octaarginine-modified liposomes enhance cross-presentation by promoting the C-terminal trimming of antigen peptide.
Nakamura T; Ono K; Suzuki Y; Moriguchi R; Kogure K; Harashima H
Mol Pharm; 2014 Aug; 11(8):2787-95. PubMed ID: 24901376
[TBL] [Abstract][Full Text] [Related]
3. Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.
Miura N; Akita H; Tateshita N; Nakamura T; Harashima H
Mol Ther; 2017 Apr; 25(4):1003-1013. PubMed ID: 28236573
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of polyinosine-polycytidylic acid enhances cytotoxic T cell activity and antitumor effects by octaarginine-modified liposomes encapsulating antigen, but not by octaarginine-modified antigen complex.
Nakamura T; Moriguchi R; Kogure K; Harashima H
Int J Pharm; 2013 Jan; 441(1-2):476-81. PubMed ID: 23159346
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antigen presentation and CTL activity by transduction of mature rather than immature dendritic cells with octaarginine-modified liposomes.
Homhuan A; Kogure K; Nakamura T; Shastri N; Harashima H
J Control Release; 2009 May; 136(1):79-85. PubMed ID: 19344678
[TBL] [Abstract][Full Text] [Related]
6. KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine.
Shaheen SM; Akita H; Nakamura T; Takayama S; Futaki S; Yamashita A; Katoono R; Yui N; Harashima H
Biomaterials; 2011 Sep; 32(26):6342-50. PubMed ID: 21658761
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy.
Yoshizaki Y; Yuba E; Sakaguchi N; Koiwai K; Harada A; Kono K
Biomaterials; 2014 Sep; 35(28):8186-96. PubMed ID: 24969637
[TBL] [Abstract][Full Text] [Related]
8. The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration.
Nakamura T; Yamazaki D; Yamauchi J; Harashima H
J Control Release; 2013 Oct; 171(2):216-24. PubMed ID: 23860186
[TBL] [Abstract][Full Text] [Related]
9. Intracellular fate of octaarginine-modified liposomes in polarized MDCK cells.
Fujiwara T; Akita H; Harashima H
Int J Pharm; 2010 Feb; 386(1-2):122-30. PubMed ID: 19922779
[TBL] [Abstract][Full Text] [Related]
10. Particle tracking of intracellular trafficking of octaarginine-modified liposomes: a comparative study with adenovirus.
Akita H; Enoto K; Masuda T; Mizuguchi H; Tani T; Harashima H
Mol Ther; 2010 May; 18(5):955-64. PubMed ID: 20216528
[TBL] [Abstract][Full Text] [Related]
11. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression.
Khalil IA; Kogure K; Futaki S; Harashima H
J Biol Chem; 2006 Feb; 281(6):3544-51. PubMed ID: 16326716
[TBL] [Abstract][Full Text] [Related]
12. Alternative processing for MHC class I presentation by immature and CpG-activated dendritic cells.
Chen L; Jondal M
Eur J Immunol; 2004 Apr; 34(4):952-60. PubMed ID: 15048705
[TBL] [Abstract][Full Text] [Related]
13. Influence of Endosomal Escape and Degradation of α-Galactosylceramide Loaded Liposomes on CD1d Antigen Presentation.
Nakamura T; Kuroi M; Harashima H
Mol Pharm; 2015 Aug; 12(8):2791-9. PubMed ID: 26107189
[TBL] [Abstract][Full Text] [Related]
14. New packaging method of mycobacterial cell wall using octaarginine-modified liposomes: enhanced uptake by and immunostimulatory activity of dendritic cells.
Homhuan A; Kogure K; Akaza H; Futaki S; Naka T; Fujita Y; Yano I; Harashima H
J Control Release; 2007 Jul; 120(1-2):60-9. PubMed ID: 17467840
[TBL] [Abstract][Full Text] [Related]
15. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
[TBL] [Abstract][Full Text] [Related]
16. Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape.
El-Sayed A; Khalil IA; Kogure K; Futaki S; Harashima H
J Biol Chem; 2008 Aug; 283(34):23450-61. PubMed ID: 18550548
[TBL] [Abstract][Full Text] [Related]
17. The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes.
Korsholm KS; Agger EM; Foged C; Christensen D; Dietrich J; Andersen CS; Geisler C; Andersen P
Immunology; 2007 Jun; 121(2):216-26. PubMed ID: 17302734
[TBL] [Abstract][Full Text] [Related]
18. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.
Rodriguez A; Regnault A; Kleijmeer M; Ricciardi-Castagnoli P; Amigorena S
Nat Cell Biol; 1999 Oct; 1(6):362-8. PubMed ID: 10559964
[TBL] [Abstract][Full Text] [Related]
19. Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens.
Gao J; Ochyl LJ; Yang E; Moon JJ
Int J Nanomedicine; 2017; 12():1251-1264. PubMed ID: 28243087
[TBL] [Abstract][Full Text] [Related]
20.
Del Balzo D; Capmany A; Cebrian I; Damiani MT
Front Immunol; 2021; 12():662096. PubMed ID: 33936099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]